Peritoneal Dialysis Solutions Containing Glycerol and Amino Acids

Rottembourg J. Quel est le meilleur liquide de dialyse péritonéale? Nephrologie 1989; 10(Suppl): 34–8.

Khanna R. Peritoneal dialysis in diabetic end-stage renal disease patients. In: Twardowski Z, Nolph KD, Khanna R, eds. Peritoneal dialysis: contemporary issues in nephrology. 1990; 22: 211–29.

Daniels F.H. , Leonard E.F. , Cortell S. Glucose and glycerol compared as osmotic agents for peritoneal dialysis. Kidney Int 1984; 25: 20–5.

Gokal R. , Ramos J.M. , MacGurk J.G. Hypertriglyceridemiain patients on CAPD. In: Gahl G.M. , Kessel M. , Nolph K.D. , eds. Advances in peritoneal dialysis. Amsterdam: Excerpta Medica, 1981: 430–3.

Lindholm B. , Bergstrom J. Nutritional aspects of peritoneal dialysis. In: Gokal R. , ed. Continuous ambulatory peritoneal dialysis. Edinburgh: Churchill Livingstone, 1986: 228–64.

Lameire N. , Matthys D. , Matthys E. , Beheyt R. Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol 1988; 30: S53–8.

Lameire N , Vanholder R. , Vijt D. , Lambert M.C. , Ringoir S. A longitudinal five-year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992; 42: 426–32.

Passlick-Deetjen J. The importance of biocompatibility in peritoneal dialysis solutions. Perit Dial Int 1993; 13: S101–4.

Kaysen G.A. , Schoenfeld Y. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25: 107–14.

Dombros N.V. , Digenis G.E. , Oreopoulos D.G. Malnutrition in continuous ambulatory peritoneal dialysis and use of intraperitoneal amino acids. In: Berlyne G.M. , ed. The kidney today. Contrib Nephrol, Basel, Karger, 1992; 100: 188–206.

Fenton S.S.A. , Johnston N. , Delmore T. Nutritional assessment of continuous ambulatory peritoneal dialysis patients. Trans Am Soc Artif Intern Organs 1987; 33: 650–3.

Young G.A. , Kopple J.D. , Lindholm B. Nutritional assessment of continuous ambulatory peritoneal dialysis patients. An international study. Am J Kidney Dis 1991; 17: 462–71.

Teehan B.P. , Schleifer C.R. , Brown J.M. , Sigler M.H. , Raimondo J. Urea kinetic analysis and clinical out come on CAPD: a five-year longitudinal study. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in continuous ambulatory peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1990; 6: 181–6.

Blake P.G. , Sombolos K. , Izatt S. , Oreopoulos D.G. Correlation between low serum albumin and poor outcome in CAPD. Perit Dial Int 1991; 11(Suppl): S24.

Dobbie J.W. New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 1990; 15: 97–109.

Goodship T.H. , Lloyd S. , McKenzie P.W. Short-term studies of the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 1987; 73: 471–8.

Williams P.F. , Marliss E.B. , Oren A. Amino acid absorption following intraperitoneal administration in CAPD patients. Perit Dial Bull 1982; 2: 129–30.

Lindholm B. , Werynski A. , Bergstrom J. Peritoneal dialysis with amino acid solutions: fluid and solute transport kinetics. ArtifOrgans 1988; 12: 2–10.

Matthys D. , Lameire N. Kinetic study of a 1% mixture of amino acids for CAPD. In: Lameire N, Ringoir S, eds. Continuous ambulatory peritoneal dialysis. Fifth Benelux Symposium, 1986: 85–105.

Young G.A. , Dibble J.B. , Hobson S.M. The use of amino acid based CAPD fluid over twelve weeks. Nephrol Dial Transplant 1989; 4: 285–92.

Bruno M. , Bagnis C. , Marangella M. , Rovera L. , Cantaluppi A. , Linari F. CAPD with an amino acid dialysis solution: a long-term cross-over study. Kidney Int 1989; 35: 1189–94.

Canepa A. , Perfumo F. , Carrea A. Long-termeffect of amino acid dialysis solution in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol 1991; 5: 215–19.

Goodship T.H. , Arfeen S. , Kirkwood A. , Wilkinson R. , Ward M.K. Amino acid dialysate. In: Coles G.A. , Davies M. , Williams J.D. , eds. CAPD: host defence, nutrition and ultrafiltration. Contrib Nephrol, Karger, Basel, 1990; 85: 84–91.

Dibble J.B. , Young G.A. , Hobson S.M. , Brownjohn A.M. Amino acid-based continuous ambulatory peritoneal dialysis (CAPD) fluid over twelve weeks: effects on carbohydrate and lipid metabolism. Perit Dial Int 1990; 10: 71–7.

Oren A. , Wu G. , Anderson E. Effective use of amino acid dialysate over four weeks in CAPD patients. Trans Am Soc Artif Intern Organs 1983; 29: 604–10.

Lindholm B. , Park M.S. , Bergstrom J. Supplemented dialysis: amino acid-based solutions in peritoneal dialysis. In: Bonomini V. , ed. Evolution in dialysis adequacy. Contrib Nephrol, Basel, Karger 1993; 103: 168–82.

Jones M.R. , Martis L. , Algrim C.E. Amino acid solutions for CAPD: rationale and clinical experience. Miner Electrolyte Metab 1992; 18: 309–15.

May R.C. , Kelly R.A. , Mitch W.E. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 1986; 77: 614–21.

Hara Y. , May R.C. , Kelly R.A. Acidosis, not azotemia, stimulates branched-chain, amino acid catabolism in uremic rats. Kidney Int 1987; 32: 808–14.

Park M.S. , Heimbürger O. , Bergstrom J. , Waniewski J. , Werynski A. , Lindholm B. Peritoneal transport during dialysis with amino acid-based solutions. Perit Dial Int 1993; 12: 280–8.

Bernard D. , Kopple J.D. , Brunori G. Nutritional benefits of intraperitoneal amino acids in CAPD patients. Abstracts of the sixth International Congress on Nutrition and Metabolism in Renal Disease, Harrogate, UK, 1991; Abstract 130.

Wolfe B.M. , Culebras J.M. , Sim A.J.W. , Ball M.R. , Moore F.D. Substrate interaction in intravenous feeding. Comparative effects of carbohydrate and fat on amino acid utilisation in fasting man. Ann Surg 1977; 186: 518–39.

Elwyn D.J. , Gump F.E. , lies M. , Long C.L. , Kinney J.M. Protein and energy sparing of glucose added in hypocaloric amounts to peripheral infusions of amino acids. Metabolism 1978; 27: 325–31.

Tao R.C. , Kelley R.E. , Yoshimura N.N. , Benjamin F. Glycerol: its metabolism and use as an intravenous energy source. J Parent Enterol Nutr 1983; 7: 479–88.

Frank M.S.B. , Mahata M.C. , Hilty M.D. Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions and clinical use. Pharmacotherapy 1981; 1: 147–60.

Steele R. , Winkler B. , Altszuler N. Inhibition by infused glycerol of glyconeogenesis from other precursors. Am J Physiol 1971; 221: 883–8.

Heaton A. , Ward M.K. , Johnston D.G. , Nicholson D.V. , Alberti K.G.M.M. , Kerr D.N.S. Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 1984; 67: 121–30.

Eden E. , Edstrom S. , Bennegard K. , Lindmark L. , Lundholm K. Glycerol dynamics in weight-Iosing cancer patients. Surgery 1985; 97: 176–84.

Heaton A. , Johnston D.G. , Ward M.K. , Alberti K.G.M.M. , Kerr D.N.S. Glycerol instead of dextrose as an osmotic agent in CAPD. In: Maher J.F. , Winchester F.J. , eds. Frontiers in peritoneal dialysis. New York: Field, Rich & Assoc, 1986: 255–70.

de Paepe M. , Matthys E. , Peluso F. , Dolkart R. , Lameire N. Experience with glycerol as the osmotic agent in peritoneal dialysis in diabetic and non-diabetic patients. In: Keen H. , Legrain M. , eds. Prevention and treatment of diabetic nephropathy. Lancaster: MTP Press, 1983: 299–313.

Matthys E. , Dolkart R. , Lameire N. Extended use of a glycerol-containing dialysate in diabetic CAPD patients. Perit Dial Bull 1987; 7: 10–15.

Matthys E. , Dolkart R. , Lameire N. Potential hazards of glycerol dialysate in diabetic CAPD patients. Perit Dial Bull 1987; 7: 16–19.

Culebras J.M. , Brennan M.F. , Fitzpatrick G.F. , Moore F.D. Nitrogen-sparing in normal man: effect of glycerol and amino acids given peripherally. Surg Forum 1976; 62: 37–9.

Fairfull-Smith R.J. , Stoski D. , Freeman J.B. Use of glycerol in peripheral parenteral nutrition. Surgery 1982; 92: 728–31.

Freeman J.B. , Fairfull- Smith R. , Rodman G.H. , Bernstein D.M. , Gazzaniga A.B. , Gersovitz M. Safety and efficacy of a new peripheral intravenously administered amino acid solution containing glycerol and electrolytes. Surg Gynecol Obstet 1983; 156: 625–31.

Waxman K. , Day A.T. , Stellin G. , Tominaga D.T. , Gazzaniga A.B. , Bradford R.R. Safety and efficacy of glycerol and amino acids in combination with lipid emulsion for peripheral parenteral nutrition support. J Parent Enterol Nutr 1992; 16: 374–8.

Lev-Ran A. , Johnson M. , Hwang D.L. , Askanazi J. , Weissman C. , Gersovitz M. Double blind study of glycerol versus glucose in parenteral nutrition of postsurgical insulin-treated diabetic patients. J Parent Enterol Nutr 1987; 11: 271–4.

Breborowicz A. In vitro study on the biocompatibility of the peritoneal dialysis solution. Perit Dial Int 1993; 13(Suppl 2): S105–8.

de Fijter C.W.H. , Verbrugh H.A. , Oe P.L. The effect of glycerol peritoneal dialysis fluid on peritoneal macrophage (PMO) function in viuo. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in continuous ambulatory peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1991; 7: 154–7.

Topley N. , Mackenzie R. , Petersen M.M. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant 1991; 6: 574–81.

Faict D. , Lameire N. , Kesteloot D. , Peluso F. Evaluation of peritoneal dialysis solutions with amino acids and glycerol in a rat model. Nephrol Dial Transplant 1991; 6: 120–4.